BPC-157 has a molecular weight of approximately 1,419 Daltons, consisting of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
SCFAs, including acetate, propionate, and butyrate, exert protective effects on kidney diseases through the modulation of inflammation and oxidative stress, primarily via the activation of G protein-coupled receptors, leading to reduced pro-inflammatory cytokine production, lowered oxidative stress markers, thereby improved renal function ( Table 1 ) [89]
Thus, modulating the Fc:FcRn interaction to prolong plasma half-life and attain a favorable biodistribution is a clinical success, and several clinical-stage candidate therapeutics harbor either the YTE or LS amino acid substitutions, or a more recently reported triple Fc mutant variant (Q311R/M428E/N434W
This releases platelet-derived growth factor (PDGF) , vascular endothelial growth factor (VEGF) , epidermal growth factor (EGF) , and fibroblast growth factor (FGF)
Integrative Peptides' best-selling product, BPC-157, contains 500mcg of the systemically active, multi-function peptide in a new peppermint-flavored oral spray format.*
